Knightsbridge Asset Management LLC acquired a new position in shares of HCA Healthcare Inc (NYSE:HCA) during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm acquired 110,421 shares of the company’s stock, valued at approximately $10,711,000. HCA Healthcare accounts for 6.7% of Knightsbridge Asset Management LLC’s holdings, making the stock its 4th largest holding.
Other hedge funds have also recently bought and sold shares of the company. Magellan Asset Management Ltd increased its position in shares of HCA Healthcare by 39.1% in the fourth quarter. Magellan Asset Management Ltd now owns 16,660,349 shares of the company’s stock worth $1,463,445,000 after purchasing an additional 4,681,672 shares during the period. Lyrical Asset Management LP bought a new position in shares of HCA Healthcare in the fourth quarter worth $324,051,000. BlackRock Inc. boosted its stake in HCA Healthcare by 2.0% in the fourth quarter. BlackRock Inc. now owns 22,002,879 shares of the company’s stock valued at $1,932,733,000 after buying an additional 433,283 shares in the last quarter. Trustcore Financial Services LLC acquired a new stake in HCA Healthcare in the fourth quarter valued at about $34,450,000. Finally, Sterling Capital Management LLC boosted its stake in HCA Healthcare by 20.3% in the fourth quarter. Sterling Capital Management LLC now owns 2,046,827 shares of the company’s stock valued at $179,793,000 after buying an additional 345,243 shares in the last quarter. Hedge funds and other institutional investors own 70.32% of the company’s stock.
Several research firms recently weighed in on HCA. Mizuho began coverage on HCA Healthcare in a research note on Friday, March 23rd. They issued a “buy” rating and a $115.00 price objective on the stock. Zacks Investment Research lowered HCA Healthcare from a “buy” rating to a “hold” rating in a research note on Tuesday, March 20th. Four research analysts have rated the stock with a sell rating, six have given a hold rating and sixteen have given a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and an average target price of $105.95.
Shares of HCA stock opened at $105.89 on Tuesday. HCA Healthcare Inc has a 12 month low of $71.18 and a 12 month high of $107.37. The stock has a market cap of $37.20 billion, a PE ratio of 16.08, a PEG ratio of 1.04 and a beta of 0.51. The company has a current ratio of 1.39, a quick ratio of 1.17 and a debt-to-equity ratio of -7.13.
HCA Healthcare (NYSE:HCA) last issued its quarterly earnings data on Tuesday, May 1st. The company reported $2.33 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $2.07 by $0.26. HCA Healthcare had a negative return on equity of 55.50% and a net margin of 5.96%. The company had revenue of $11.42 billion during the quarter, compared to the consensus estimate of $11.29 billion. During the same period last year, the company earned $1.74 earnings per share. The firm’s revenue was up 7.5% compared to the same quarter last year. equities analysts predict that HCA Healthcare Inc will post 8.83 EPS for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, June 29th. Stockholders of record on Friday, June 1st will be given a dividend of $0.35 per share. The ex-dividend date is Thursday, May 31st. This represents a $1.40 dividend on an annualized basis and a dividend yield of 1.32%. HCA Healthcare’s dividend payout ratio (DPR) is 21.24%.
In other news, insider Jonathan B. Perlin sold 11,520 shares of the firm’s stock in a transaction dated Thursday, May 17th. The stock was sold at an average price of $104.00, for a total transaction of $1,198,080.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Kathryn A. Torres sold 1,750 shares of the firm’s stock in a transaction dated Wednesday, June 13th. The stock was sold at an average price of $106.87, for a total value of $187,022.50. Following the transaction, the senior vice president now owns 9,494 shares of the company’s stock, valued at $1,014,623.78. The disclosure for this sale can be found here. Insiders have sold 39,474 shares of company stock valued at $4,161,523 over the last 90 days. 2.80% of the stock is owned by corporate insiders.
About HCA Healthcare
HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare Inc (NYSE:HCA).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.